Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2558-2025

Vercise Deep Brain Stimulation Systems Surgical Implant Manual, Document Number: 92328632-09 Recall

Vercise Deep Brain Stimulation Systems Surgical Implant Manual, Document Number: 92328632-09

FDA recall Class II

Ongoing

FDA lists this Class II recall for Vercise Deep Brain Stimulation Systems Surgical Implant Manual, Document Number: 92328632-09. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2558-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jul 8, 2025
FDA report date
Sep 24, 2025
Quantity in commerce
25,260
Distribution
See key details
FDA cause
Labeling design

What is being recalled?

Vercise Deep Brain Stimulation Systems Surgical Implant Manual, Document Number: 92328632-09

Affected model & UDI checker

Search the exact identifiers published for Z-2558-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedVercise Deep Brain Stimulation Systems Surgical Implant Manual, Document Number: 92328632-09Check source notice08714729985044
Not specifiedVercise Deep Brain Stimulation Systems Surgical Implant Manual, Document Number: 92328632-09Check source notice08714729985051
FDA code information

UDI-DI: 08714729985044, 08714729985051. Document Number/Revision: 92328632-09, Rev A

View the original FDA recall notice

Why was this product recalled?

Wire break(s) have occurred in rechargeable deep brain stimulation implantable pulse generators, implanted in the submuscular pectoral location. Wire breaks prevent successful stimulation, thus requiring device removal/replacement and users may experience high monopolar impedances, undesired sensation, loss of therapy, return of symptoms and/or Bluetooth connectivity challenges.

What actions did Boston Scientific Neuromodulation Corporation take?

On 7/8/2025, correction notices were mailed in the U.S. and mailed, emailed, or hand delivered outside the U.S. Healthcare Professionals were asked to do the following: 1) Review the Surgical Implant Manual updates. 2) If you are a facility that has sent products to another hospital or a facility within your network, ensure this notification is forwarded to them. 3) A patient letter is enclosed with this communication, which can be shared with your patient and/or included within the patient's medical record. 4) Monitor per relevant IFU recommendations for any clinical observations of high monopolar impedances, undesired sensation, sudden loss of therapy, return of pre-implant symptoms and/or Bluetooth connectivity challenges, as these may be signals of potential feedthrough wire break(s) (component damage). 5) If you are a distributor, this notification must be forwarded to your customers to ensure this notification is carried out to the end-user level. 6) To provide awareness of this information, share this letter with any other clinicians in your hospital who use the system. 7) Maintain a copy of this letter in your facility's records. 8) Complete and return the acknowledgement form via email to [email protected] report all device-related incidents or quality concerns experienced with the use of these devices to the firm at [email protected]

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology